Priscilla Chassama: Expanding Healthcare Access for Children Living with Sickle Cell Disease in Geita
Priscilla Chassama, Project Manager at Tanzania Sicklecell Warriors Organisation (TASIWA), shared a post on LinkedIn:
“As part of our ongoing efforts to improve access to healthcare for children living with sickle cell disease in Geita, we recently conducted an enrollment exercise for more than 70 parents into our health insurance support initiative, a project that will benefit over 300 children.
Through this project, many children have been identified early and linked to timely treatment and care in the health facilities we continue to support and strengthen.
Children diagnosed with sickle cell disease are also benefiting from health insurance support, helping families manage the cost of treatment and improving access to essential healthcare services.
Beyond enrollment, the session also provided an important opportunity to educate parents on sickle cell disease, the importance of birth certificates, and the key documents required throughout the health insurance application process.
Parents also had the opportunity to better understand the importance of health insurance for children living with sickle cell disease, as well as for children without sickle cell disease.
It was also a meaningful moment to connect with parents, share experiences on caregiving, and learn together about better ways to care for and raise children living with sickle cell disease.
We sincerely appreciate the support of Fondation Pierre Fabre for making this initiative possible and for continuing to support efforts toward early diagnosis, access to treatment, and improved quality of life for children living with sickle cell disease in Geita.”
Stay updated with HemostasisToday.
-
Aug 27, 2026, 11:08Sunisha Arora: New EBMT Recommendations Transform the Approach to HSCT in Thalassemia
-
Aug 27, 2026, 10:51Seema Dawood: A Layered Approach to Identifying Thalassemia in the Laboratory
-
Aug 27, 2026, 10:44Ed Smith: Vitalant Expands Hemophilia Center Team With New Career Opportunities
-
Aug 27, 2026, 10:43FDA Expands Hympavzi Approval to Children and Patients With Hemophilia A or B With Inhibitor
-
Aug 27, 2026, 10:28Narat Srivali: Exploring the Link Between Perioperative Corticosteroids and VTE Risk
-
Aug 27, 2026, 10:19Vincent Poher: Clinical Validation of Rapid Whole-Blood Fibrinogen Measurement
-
Aug 27, 2026, 07:49Denis Oduor: Bringing Blood Closer – Strengthening Kenya’s Response to PPH
-
Aug 27, 2026, 07:19Luis Oliverio Ambriz Garcia: ASH 2026 Guidelines – What’s New in ITP?
-
Aug 27, 2026, 06:58Priyam Bordoloi: The Biological Advantage of Two X Chromosomes